BALAXI PHARMACEUTICALS
Back to Balance Sheet
|
BALAXI PHARMACEUTICALS Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹1.00 Cr | ₹1.10 Cr | ₹0.04 Cr | ₹0.01 Cr | ₹0.00 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of BALAXI PHARMACEUTICALS ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹1.00 Cr |
Mar2023 | ₹1.10 Cr |
Mar2022 | ₹0.04 Cr |
Mar2021 | ₹0.01 Cr |
Mar2020 | ₹0.00 Cr |
How is Deferred Tax Assets / Liabilities of BALAXI PHARMACEUTICALS Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹1.00 Cr | -9.63 | |
Mar2023 | ₹1.10 Cr | 2,723.08 | |
Mar2022 | ₹0.04 Cr | 457.14 | |
Mar2021 | ₹0.01 Cr | 133.33 | |
Mar2020 | ₹0.00 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of BALAXI PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BALAXI PHARMACEUTICALS | ₹397.4 Cr | -2.2% | -11.5% | -17.5% | Stock Analytics | |
ADANI ENTERPRISES | ₹295,009.0 Cr | 6.4% | 4.1% | -10.1% | Stock Analytics | |
REDINGTON | ₹15,588.6 Cr | -3.7% | -0.9% | 12.3% | Stock Analytics | |
MMTC | ₹11,107.5 Cr | 2.2% | -9.1% | 22.2% | Stock Analytics | |
HONASA CONSUMER | ₹8,094.6 Cr | -1% | -5% | -44.6% | Stock Analytics | |
MSTC | ₹4,781.9 Cr | 0.7% | -9.4% | 5.5% | Stock Analytics |
BALAXI PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BALAXI PHARMACEUTICALS | -2.2% |
-11.5% |
-17.5% |
SENSEX | 0% |
-1.6% |
9% |
You may also like the below Video Courses